These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1960880)

  • 1. [Chronic arterial occlusive diseases--drug therapy and thromboxane A2 synthetase inhibitor].
    Yasuda K; Matsui Y; Goda T; Sakuma M; Go K
    Nihon Rinsho; 1991 Sep; 49(9):2149-54. PubMed ID: 1960880
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitor of thromboxane A2 synthesis as anticoagulant in hemodialysis].
    Iida N
    Nihon Rinsho; 1991 Dec; 49 Suppl():746-52. PubMed ID: 1839689
    [No Abstract]   [Full Text] [Related]  

  • 3. (E)-7-Phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151): a potent, specific thromboxane A2 synthetase inhibitor.
    Nishikawa K; Terashita Z; Imamoto T; Imura Y; Hirata M; Terao S
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():523-5. PubMed ID: 2936160
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis model.
    Imura Y; Kiyota Y; Nagai Y; Nishikawa K; Terashita Z
    Thromb Res; 1995 Jul; 79(1):95-107. PubMed ID: 7495108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
    Niwa T; Nomura T; Ozawa Y; Maeda K; Shibata M
    Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):655-65. PubMed ID: 3682335
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S; Wakitani K; Katsube N; Kawasaki A; Tsuboshima M; Naito J; Ujiie A; Komatsu H; Iizuka K
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():241-4. PubMed ID: 6221530
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151).
    Tanabe K; Toma H; Sagara R; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):293-5. PubMed ID: 2650124
    [No Abstract]   [Full Text] [Related]  

  • 8. Angioscopic study of the antithrombotic effect of a new selective thromboxane A2 synthetase inhibitor, CV-4151, on experimental arterial thrombi.
    Matsubara T; Yamazoe M; Tamura Y; Igarashi Y; Izumi T; Shibata A
    Am Heart J; 1989 Oct; 118(4):837-9. PubMed ID: 2529751
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective thromboxane synthase inhibition does not increase in vivo synthesis of prostacyclin in healthy humans.
    Vesterqvist O; Gréen K; Henriksson P; Rasmanis G; Edhag O
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():165-8. PubMed ID: 1825536
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective effects of selective inhibitor of thromboxane synthetase (OKY-046) and thromboxane antagonist (ONO-3708) on ischemia-induced mitochondrial dysfunction in canine heart.
    Ito T; Ito Y; Torii T; Hieda N; Toki Y; Miyazaki Y; Hashimoto H; Ogawa K; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():392-6. PubMed ID: 2959085
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of thromboxane A2 synthase inhibitors (CV-4151 and ozagrel), aspirin, and ticlopidine on the thrombosis caused by endothelial cell injury.
    Terashita Z; Imura Y; Kawamura M; Kato K; Nishikawa K
    Thromb Res; 1995 Mar; 77(5):411-21. PubMed ID: 7778056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
    Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
    J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thromboxane A2 synthetase inhibitor in asthma therapy].
    Machida K; Takagi K; Horiba M
    Nihon Rinsho; 1996 Nov; 54(11):3034-9. PubMed ID: 8950950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Highlights of thromboxane synthetase inhibitor research].
    Yu WG; Xu LN
    Sheng Li Ke Xue Jin Zhan; 1990 Jul; 21(3):216-20. PubMed ID: 2244198
    [No Abstract]   [Full Text] [Related]  

  • 15. Arachidonate metabolism in vascular disorders.
    Majerus PW
    J Clin Invest; 1983 Nov; 72(5):1521-5. PubMed ID: 6313764
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of endothelin-induced bronchoconstriction by OKY-046, a selective thromboxane A2 synthetase inhibitor, in guinea pigs.
    Nambu F; Yube N; Omawari N; Sawada M; Okegawa T; Kawasaki A; Ikeda S
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():453-6. PubMed ID: 1825581
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of endogenous thromboxane A2 biosynthesis mediates presynaptic inhibition by endothelin-3 of dog stellate ganglionic transmission.
    Kushiku K; Ohjimi H; Yamada H; Kuwahara T; Furukawa T
    J Pharmacol Exp Ther; 1995 Jan; 272(1):70-6. PubMed ID: 7815366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
    Aiken JW; Shebuski RJ; Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1981 Nov; 219(2):299-308. PubMed ID: 6270303
    [No Abstract]   [Full Text] [Related]  

  • 19. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. VI. Indazole derivatives.
    Yamaguchi M; Maruyama N; Koga T; Kamei K; Akima M; Kuroki T; Hamana M; Ohi N
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):332-4. PubMed ID: 7728936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.